JP2023510491A5 - - Google Patents
Info
- Publication number
- JP2023510491A5 JP2023510491A5 JP2022534852A JP2022534852A JP2023510491A5 JP 2023510491 A5 JP2023510491 A5 JP 2023510491A5 JP 2022534852 A JP2022534852 A JP 2022534852A JP 2022534852 A JP2022534852 A JP 2022534852A JP 2023510491 A5 JP2023510491 A5 JP 2023510491A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- oligonucleotide
- oligonucleotide according
- group
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020002715 | 2020-01-10 | ||
| JP2020002715 | 2020-01-10 | ||
| PCT/JP2021/000543 WO2021141121A1 (en) | 2020-01-10 | 2021-01-08 | Novel tlr9 agonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023510491A JP2023510491A (ja) | 2023-03-14 |
| JP2023510491A5 true JP2023510491A5 (cg-RX-API-DMAC10.html) | 2023-06-19 |
| JP7750525B2 JP7750525B2 (ja) | 2025-10-07 |
Family
ID=76787976
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022534852A Active JP7750525B2 (ja) | 2020-01-10 | 2021-01-08 | 新規なｔｌｒ９アゴニスト |
Country Status (11)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022249092A1 (en) * | 2021-04-01 | 2023-10-12 | Trisalus Life Sciences, Inc. | Cancer therapy using toll-like receptor agonists |
| CN117568339A (zh) * | 2023-01-19 | 2024-02-20 | 华普生物技术(河北)股份有限公司 | CpG寡核苷酸及其应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR040996A1 (es) | 2002-08-19 | 2005-04-27 | Coley Pharm Group Inc | Acidos nucleicos inmunoestimuladores |
| RU2400538C2 (ru) | 2005-03-05 | 2010-09-27 | Сиджен, Инк. | Олигонуклеотид с двойственной специфичностью и способы, в которых он используется |
| WO2006095941A1 (en) | 2005-03-05 | 2006-09-14 | Seegene, Inc. | Processes using dual specificity oligonucleotide and dual specificity oligonucleotide |
| JP5011520B2 (ja) | 2005-08-12 | 2012-08-29 | 国立大学法人 長崎大学 | 新規ヒト形質細胞様樹状細胞株 |
| JP2010536787A (ja) | 2007-08-15 | 2010-12-02 | イデラ ファーマシューティカルズ インコーポレイテッド | Ｔｏｌｌ様受容体モジュレータ |
| US20110136897A1 (en) | 2008-08-14 | 2011-06-09 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Toll-like receptor 9 agonists for the treatment of anxiety-related disorders and inflammatory disorders |
| KR101856462B1 (ko) | 2009-03-25 | 2018-05-10 | 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 | 병원체에 대한 포유동물의 선천성 면역 저항성의 자극을 위한 조성물 |
| JP6106280B2 (ja) | 2012-11-29 | 2017-03-29 | Ｓｂｉバイオテック株式会社 | 阻害性オリゴヌクレオチド及びその使用 |
| CN105518153A (zh) | 2013-06-20 | 2016-04-20 | 因姆内克斯普雷斯私人有限公司 | 生物标志物鉴定 |
| KR102779525B1 (ko) | 2015-05-29 | 2025-03-12 | 다이나박스 테크놀로지 코퍼레이션 | 폐암을 치료하기 위한 폴리뉴클레오티드 Toll-유사 수용체 9 아고니스트의 폐내 투여 |
| EP3302501B1 (en) * | 2015-05-29 | 2021-09-22 | Merck Sharp & Dohme Corp. | Combination of a pd-1 antagonist and cpg-c type oligonucleotide for treating cancer |
| CA3020873A1 (en) | 2016-04-15 | 2017-10-19 | Dynavax Technologies Corporation | Intratumoral administration of particles containing a toll-like receptor 9 agonist and a tumor antigen for treating cancer |
| MX2019005502A (es) | 2016-11-09 | 2020-10-01 | Univ Texas | Metodos y composiciones para inmunomodulacion adaptativa. |
-
2021
- 2021-01-08 US US17/787,687 patent/US12686870B2/en active Active
- 2021-01-08 IL IL294621A patent/IL294621A/en unknown
- 2021-01-08 KR KR1020227017755A patent/KR20220125218A/ko active Pending
- 2021-01-08 WO PCT/JP2021/000543 patent/WO2021141121A1/en not_active Ceased
- 2021-01-08 CN CN202180010073.7A patent/CN114981436A/zh active Pending
- 2021-01-08 EP EP21738230.8A patent/EP4087931B1/en active Active
- 2021-01-08 MX MX2022005633A patent/MX2022005633A/es unknown
- 2021-01-08 BR BR112022007935A patent/BR112022007935A2/pt unknown
- 2021-01-08 JP JP2022534852A patent/JP7750525B2/ja active Active
- 2021-01-08 CA CA3161956A patent/CA3161956A1/en active Pending
- 2021-01-08 AU AU2021206355A patent/AU2021206355B2/en active Active